Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.
about
Disturbed copper bioavailability in Alzheimer's diseaseCholesterol increases ventricular volume in a rabbit model of Alzheimer's disease.Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.Copper and iron in Alzheimer's disease: a systematic review and its dietary implications.Effects of a copper-deficient diet on the biochemistry, neural morphology and behavior of aged mice.Copper modulation as a therapy for Alzheimer's disease?The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's disease.Copper in Alzheimer's disease: too much or too little?Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies.Advantages and challenges of increased antimicrobial copper use and copper mining.The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline.Scientific Opinion on Dietary Reference Values for copperToxicity of Alzheimer's disease-associated Aβ peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability.Role of amyloid-β–metal interactions in Alzheimer’s disease
P2860
Q28254726-543E15DC-1B73-4311-9284-B1038C539F76Q34122488-60614521-1AC0-4F4E-B338-BB83DECC3869Q34189447-BD1C6885-6E2C-471A-9C51-D51660C93BA1Q34201410-FE9BFD44-74C7-478B-903B-1B43578A475EQ34447834-7EF6C714-E5B0-4957-9554-39001D437246Q35184353-24E463C1-4B8D-4BF5-9C4D-EA6F8FA9CE3DQ35986569-8CCF02BA-6235-472A-AE39-31C641CD6A44Q37238681-E2C37F0F-AC91-45DC-9A6D-773B056348EEQ37464172-DD66614A-2DAD-43CA-A804-581B31B0E18CQ37779358-CE8D8D4E-3ED3-485D-A762-1AFA48577F82Q37886825-879C8128-D264-43E0-9578-47A7D985FE55Q42164137-E6BCCF64-D67E-4A96-8E07-E97828A759F1Q47157342-B2E6BD51-F485-4010-8791-08FD645018DAQ52725312-20E5A5C9-6B4A-4156-8E8C-4AD31D55192BQ58842294-347E9ECE-FF06-40C8-9023-C901B52A18F3
P2860
Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@ast
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@en
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@nl
type
label
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@ast
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@en
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@nl
prefLabel
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@ast
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@en
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@nl
P2093
P2860
P50
P1476
Effect of copper intake on CSF ...... pilot phase 2 clinical trial.
@en
P2093
Daniela Bach
Frank-Gerald Pajonk
Holger Kessler
Stephanie Schäfer
Thomas A Bayer
Wolfgang Herrmann
P2860
P2888
P304
P356
10.1007/S00702-008-0136-2
P577
2008-10-30T00:00:00Z